Melanie Simpson

13PUBLICATIONS
32CO-AUTHORS
Molecular medicineCancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsNanotoxicology, health and safetyMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 12, 2026
Serum Concentration Relationships of Candesartan in Migraine Prevention.

|Jun 29, 2026
Stage 1 Registered Report: Rationale, design and study protocol for a prospective, exploratory study Predicting Response to image-Guided Cryoneurolysis of the Greater Occipital Nerve (CryoGON) in Chronic Migraine Using a Conventional Greater Occipital Nerve Block.

|Feb 23, 2026
OnabotulinumtoxinA blockade of the sphenopalatine ganglion in treatment-resistant chronic migraine (MiBlock): rationale, design and study protocol for a multi-centre, investigator initiated, randomised, quadruple-blinded placebo-controlled trial.

Tore Wergeland, Melanie Simpson, Irina Aschehoug

|Sep 05, 2025
Biofeedback therapy using Cerebri for the prevention of migraine attacks in adults with episodic migraine (BioCer): a randomized, wait-list controlled trial - the study protocol.

Amalie Christine Poole, Anker Stubberud, Melanie Simpson

|Jun 09, 2025
Feasibility of a 12-Week, Therapist-Independent, Smartphone-Based Biofeedback Treatment for Episodic Migraine in Adults: Single-Center, Open-Label, 1-Armed Trial.

Amalie Christine Poole, Ingunn Grøntveit Winnberg, Melanie Rae Simpson

|Apr 18, 2024
Enteroaggregative Escherichia coli in mid-Norway: A prospective, case control study.

Ingvild Haugan, Marit Gudrun Husby, Bjørg Skjøtskift

Pageof 3

Frequent Collaborators

4 joint publications

Tore Wergeland Meisingset

2 joint publications

Erling Tronvik

2 joint publications

Alexander Olsen

2 joint publications

Marte-Helene Bjørk